University of South Florida

https://www.usf.edu/

Already a Biomedtracker subscriber? You have access to the full company record through your subscription

Want to become a subscriber? Subscribers get more company details, updates, company financials and company products.

Questions?

Please contact Sales at: (212) 520-2765 or email [email protected]

Finance Watch: Kyverna, Alto Offerings Could Land In IPO Investors’ Sweet Spot

Bookmark

17 Jan 2024
Analysis

By Mandy Jackson

Public Company Edition: Kyverna and Alto Neuroscience, which may go public in the US this year, have drug candidates in or nearing mid-stage trials. Also, Zealand’s private placement raises $211.4m, Praxis prices a $150m offering and Solid grosses $108.9m in stock sale.

Financing Growth

Asia Deal Watch: Argo Partners RNAi Programs With Novartis In Major Biobucks Pact

Bookmark

08 Jan 2024
News

By Joseph Haas and Jung Won Shin

Plus deals involving Biocytogen/Radiance, Maruho/AOBiome, LGChem/Rhythm, IASO/Umoja, JW Therapeutics/2seventy and 13 other transactions.

Deal Watch Business Strategies

Marinus On Track To Be Leader In Rare Epilepsy Market, Says CEO

Bookmark

09 Aug 2023
Interviews

By Lucie Ellis-Taitt

CEO Scott Braunstein, who took leadership of Marinus in 2019 following clinical trial setbacks, believes the company is on a route to success with its ganaxolone program, targeting chronic use and hospital markets.

Neurology Research & Development